John P. McLaughlin
2009
In 2009, John P. McLaughlin earned a total compensation of $1.1M as President, Chief Executive Officer and Acting Chief Financial Officer at PDL BioPharma, a 292% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $262,500 |
|---|---|
| Salary | $500,000 |
| Stock Awards | $300,000 |
| Other | $9,800 |
| Total | $1,072,300 |
McLaughlin received $500K in salary, accounting for 47% of the total pay in 2009.
McLaughlin also received $262.5K in non-equity incentive plan, $300K in stock awards and $9.8K in other compensation.
Rankings
In 2009, John P. McLaughlin's compensation ranked 4,229th out of 9,885 executives tracked by ExecPay. In other words, McLaughlin earned more than 57.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,229 out of 9,885 | 57th |
Division Manufacturing | 1,505 out of 3,690 | 59th |
Major group Chemicals And Allied Products | 287 out of 866 | 67th |
Industry group Drugs | 173 out of 638 | 73rd |
Industry Biological Products, Except Diagnostic Substances | 29 out of 133 | 78th |
Source: SEC filing on April 23, 2012.
McLaughlin's colleagues
We found three more compensation records of executives who worked with John P. McLaughlin at PDL BioPharma in 2009.